These findings allow for speculation that, during HCC transformation, Gln metabolism switches from GLS2- to GLS-dependent; they are consistent with an earlier study on MYC-induced mouse liver tumors [92]. The gene discussed is GLS2; the disease is hepatocellular carcinoma.